The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Virupaksha Organics Ltd, the promoter of Oxygenta Pharmaceutical Ltd, bought 2,23,632 equity shares in the open market on 13-02-2026. This raised its holding from 2,06,73,343 shares (55.90%) to 2,08,96,975 shares (56.50%), a 0.60 percentage point increase. The transaction was disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, and the shares are listed on BSE (Scrip Code: 524636). The equity share capital of the company remained unchanged at 3,69,83,500 shares of Rs. 10 each. The purchase signals continued promoter confidence in the company through incremental buying.
Modest positive signal for retail investors as the promoter is adding to its stake, indicating confidence in the business. The 0.60% incremental purchase is unlikely to move the stock price materially on its own, but reinforces promoter commitment at a dominant 56.50% holding level.